453 related articles for article (PubMed ID: 22931165)
1. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
[TBL] [Abstract][Full Text] [Related]
2. Transfection of T-Box Transcription Factor
Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle.
Kobayashi Y; Sugiura T; Imajyo I; Shimoda M; Ishii K; Akimoto N; Yoshihama N; Mori Y
Int J Oncol; 2014 Apr; 44(4):1107-17. PubMed ID: 24504414
[TBL] [Abstract][Full Text] [Related]
4. Involvement of epithelial-mesenchymal transition in adenoid cystic carcinoma metastasis.
Ishii K; Shimoda M; Sugiura T; Seki K; Takahashi M; Abe M; Matsuki R; Inoue Y; Shirasuna K
Int J Oncol; 2011 Apr; 38(4):921-31. PubMed ID: 21258767
[TBL] [Abstract][Full Text] [Related]
5. T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma.
Imajyo I; Sugiura T; Kobayashi Y; Shimoda M; Ishii K; Akimoto N; Yoshihama N; Kobayashi I; Mori Y
Int J Oncol; 2012 Dec; 41(6):1985-95. PubMed ID: 23076115
[TBL] [Abstract][Full Text] [Related]
6. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
Song W; Gobe GC
Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
[TBL] [Abstract][Full Text] [Related]
7. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
[TBL] [Abstract][Full Text] [Related]
8. The T-box transcription factor Brachyury promotes renal interstitial fibrosis by repressing E-cadherin expression.
Sun S; Sun W; Xia L; Liu L; Du R; He L; Li R; Wang H; Huang C
Cell Commun Signal; 2014 Nov; 12():76. PubMed ID: 25433496
[TBL] [Abstract][Full Text] [Related]
9. An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype.
Larocca C; Cohen JR; Fernando RI; Huang B; Hamilton DH; Palena C
Mol Cancer Ther; 2013 Sep; 12(9):1805-15. PubMed ID: 23783250
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
13. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
14. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
15. Bmi-1 expression predicts prognosis in salivary adenoid cystic carcinoma and correlates with epithelial-mesenchymal transition-related factors.
Yi C; Li BB; Zhou CX
Ann Diagn Pathol; 2016 Jun; 22():38-44. PubMed ID: 27180058
[TBL] [Abstract][Full Text] [Related]
16. Expression of integrin-linked kinase in adenoid cystic carcinoma of salivary glands correlates with epithelial-mesenchymal transition markers and tumor progression.
Zhao D; Yang K; Tang XF; Lin NN; Liu JY
Med Oncol; 2013; 30(3):619. PubMed ID: 23729269
[TBL] [Abstract][Full Text] [Related]
17. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
[TBL] [Abstract][Full Text] [Related]
18. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
19. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.
Hamilton DH; Litzinger MT; Fernando RI; Huang B; Palena C
Semin Oncol; 2012 Jun; 39(3):358-66. PubMed ID: 22595058
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
